The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)

Filter results
Date Title Content PDF
8/05/2019 Information on P&L ROVI releases the press release related to the first quarter 2019 financial results
8/05/2019 Information on P&L ROVI releases the first quarter 2019 results presentation
8/05/2019 Convocatorias y acuerdos de Juntas y Asambleas generales ROVI releases the information related to its 2019 General Shareholders Meeting
7/05/2019 Liquidity contracts and specialists ROVI announces the signature of a new liquidity contract with Renta 4 Banco, S.A.    
30/04/2019 Liquidity contracts and specialists ROVI announces the termination of the liquidity contract signed with JB Capital Markets, S.V., S.A.U.    
11/04/2019 Strategic agreements with third parties The Company releases the press release related to the marketing agreement of Tetridar® in Spain  
4/04/2019 Liquidity contracts and specialists Liquidity contract: transactions conducted in the first quarter of 2019
19/03/2019 R&D: new licenses, patents and registered trademarks ROVI Announces Positive Topline Results from Phase 3 study of Doria® in Patients with Schizophrenia
26/02/2019 Informe Anual de Remuneraciones de los Consejeros ROVI releases the 2018 annual report regarding remuneration of the members of the Board of Directors 
26/02/2019 Informe Anual de Gobierno Corporativo ROVI releases the 2018 Annual Corporate Governance Report

Pages